#USA #New York #Class Action #Securities Fraud #DexCom

Important Reminder for DexCom Investors

Investors in DexCom, Inc. are being notified about an ongoing class action securities lawsuit filed by Levi & Korsinsky, LLP. The lawsuit targets alleged fraudulent activities occurring from January 8, 2024, to September 17, 2025, impacting shareholders adversely. The firm emphasizes that those affected must act quickly to ensure they can partake in any potential compensation.

What’s at Stake?

The class action seeks to hold the company accountable for purported misrepresentation regarding its flagship glucose monitoring products, particularly the G6 and G7 devices. Key allegations include:

• - Unauthorized Design Changes: It is claimed that DexCom made significant modifications to their glucose monitors that weren’t approved by the U.S. Food and Drug Administration (FDA).
• - Reliability Concerns: Allegations state that these changes have compromised the reliability of the G6 and G7 devices, posing health risks to users who depend on these devices for accurate glucose readings.
• - Misleading Enhancements: The lawsuit suggests that DexCom overstated the enhancements made to the G7, which it claimed would improve the device’s functionality.
• - Regulatory Risks: The defendants purportedly downplayed the likelihood of facing increased regulatory scrutiny and the associated legal, reputational, and financial consequences.

Deadline Alert

For those who have incurred losses during the noted timeframe, it is crucial to act by December 26, 2025, in order to have a chance at being appointed as a lead plaintiff in this case. Even if you do not wish to take this role, participating in the class cannot be understated as it may entitle you to compensation without any financial outlay.

How to Get Involved

Affected investors are encouraged to reach out to Levi & Korsinsky for further instructions. Contact details for attorney Joseph E. Levi are available for inquiries; you can get in touch via email or by phone, ensuring your participation in the lawsuit is noted before the critical deadline.

Why Choose Levi & Korsinsky?

This firm has established a solid reputation over the last two decades, managing to recover hundreds of millions for investors facing losses due to securities fraud. They specialize in representing individuals in complex securities litigations and have a dedicated team of professionals ready to assist.

As DexCom continues to navigate this tumultuous legal environment, shareholders are encouraged to stay informed and proactive about their rights and potential recovery options. Don’t miss the opportunity to advocate for your interests before it’s too late.